Abpro Holdings announces 1-for-30 reverse stock split

Abpro announced that its previously approved 1-for-30 reverse stock split of its common stock became effective at 5:01 p.m. Eastern Time on October 31, 2025. The Company’s common stock will begin trading on a split-adjusted basis at the open of trading on November 3, 2025 under the ticker symbol “ABP” and the new CUSIP number will be 000847202. “This action is a highly necessary step in our efforts to maintain our Nasdaq listing and reflects a broader realignment of Abpro for the future,” said Miles Suk, Chief Executive Officer and Chairman of Abpro. “With a leaner cost structure, a major global partner in Celltrion, and a differentiated antibody platform, we are positioned to execute more effectively and create long-term value for our shareholders.”